Yamamoto I - Search Results

1

CYP2C19 genotypes and omeprazole metabolism after single and repeated dosing when combined with clarithromycin.

Zhou Q, Yamamoto I, Fukuda T, Ohno M, Sumida A, Azuma J. Zhou Q, et al. Among authors: yamamoto i. Eur J Clin Pharmacol. 1999 Mar;55(1):43-7. doi: 10.1007/s002280050590. Eur J Clin Pharmacol. 1999. PMID: 10206083

2

Effect of the CYP2D6*10 genotype on venlafaxine pharmacokinetics in healthy adult volunteers.

Fukuda T, Yamamoto I, Nishida Y, Zhou Q, Ohno M, Takada K, Azuma J. Fukuda T, et al. Among authors: yamamoto i. Br J Clin Pharmacol. 1999 Apr;47(4):450-3. doi: 10.1046/j.1365-2125.1999.00913.x. Br J Clin Pharmacol. 1999. PMID: 10233212 Free PMC article.

3

Circadian variation of the urinary 6beta-hydroxycortisol to cortisol ratio that would reflect hepatic CYP3A activity.

Ohno M, Yamaguchi I, Ito T, Saiki K, Yamamoto I, Azuma J. Ohno M, et al. Among authors: yamamoto i. Eur J Clin Pharmacol. 2000 Feb-Mar;55(11-12):861-5. doi: 10.1007/s002280050708. Eur J Clin Pharmacol. 2000. PMID: 10805065

4

The impact of the CYP2D6 and CYP2C19 genotypes on venlafaxine pharmacokinetics in a Japanese population.

Fukuda T, Nishida Y, Zhou Q, Yamamoto I, Kondo S, Azuma J. Fukuda T, et al. Among authors: yamamoto i. Eur J Clin Pharmacol. 2000 May;56(2):175-80. doi: 10.1007/s002280050737. Eur J Clin Pharmacol. 2000. PMID: 10877013 Clinical Trial.

5

[Individualization of drug therapy and pharmacogenetics].

Yamamoto I, Azuma J. Yamamoto I, et al. Nihon Rinsho. 1998 Mar;56(3):579-83. Nihon Rinsho. 1998. PMID: 9549339 Review. Japanese.

6

The effect of Y-25510 injection on the serum levels of some cytokines in healthy adult volunteers.

Azuma J, Ogura M, Yamamoto I, Hisadome M, Fukuda T, Ikeda Y, Mori H, Oka T, Asano S. Azuma J, et al. Among authors: yamamoto i. Eur J Clin Pharmacol. 1998 Feb;53(6):411-9. doi: 10.1007/s002280050401. Eur J Clin Pharmacol. 1998. PMID: 9551699 Clinical Trial.

7

Evaluation of induction of CYP3A mRNA using the HepG2 cell line and reverse transcription-PCR.

Sumida A, Yamamoto I, Zhou Q, Morisaki T, Azuma J. Sumida A, et al. Among authors: yamamoto i. Biol Pharm Bull. 1999 Jan;22(1):61-5. doi: 10.1248/bpb.22.61. Biol Pharm Bull. 1999. PMID: 9989663 Free article.

8

Relationship between mRNA levels quantified by reverse transcription-competitive PCR and metabolic activity of CYP3A4 and CYP2E1 in human liver.

Sumida A, Kinoshita K, Fukuda T, Matsuda H, Yamamoto I, Inaba T, Azuma J. Sumida A, et al. Among authors: yamamoto i. Biochem Biophys Res Commun. 1999 Aug 27;262(2):499-503. doi: 10.1006/bbrc.1999.1233. Biochem Biophys Res Commun. 1999. PMID: 10462503

9

Quantitative analysis of constitutive and inducible CYPs mRNA expression in the HepG2 cell line using reverse transcription-competitive PCR.

Sumida A, Fukuen S, Yamamoto I, Matsuda H, Naohara M, Azuma J. Sumida A, et al. Among authors: yamamoto i. Biochem Biophys Res Commun. 2000 Jan 27;267(3):756-60. doi: 10.1006/bbrc.1999.2029. Biochem Biophys Res Commun. 2000. PMID: 10673364

10

Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity.

Ohno M, Yamaguchi I, Yamamoto I, Fukuda T, Yokota S, Maekura R, Ito M, Yamamoto Y, Ogura T, Maeda K, Komuta K, Igarashi T, Azuma J. Ohno M, et al. Among authors: yamamoto i, yamamoto y. Int J Tuberc Lung Dis. 2000 Mar;4(3):256-61. Int J Tuberc Lung Dis. 2000. PMID: 10751073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,511 results

Search Page

Filters